
HWM · NYSE
Consensus is Buy across all 17 analysts, with a mean price target of $310. The supplied consensus does not include low or high targets, so the target cluster and the width of the spread cannot be determined. No named analyst is identified as most or least bullish, and no rating or target revisions during the past week are reported. The evidence therefore cannot establish whether sentiment has strengthened or weakened recently. The substantive disagreement behind the target distribution is also unavailable: the material provides only the aggregate mean, while the earnings coverage focuses on projected second-quarter metrics and the possibility that Howmet may not deliver a beat.